Suppr超能文献

加强对黄热病病毒进行研究的实验室的生物安全协议。

Enhancing Biosafety Protocols in Laboratories Conducting Research on the Yellow Fever Virus.

作者信息

Fernandes Alice Gomes

机构信息

Nuclear Magnetic Resonance (NMR) Platform, Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil.

Laboratory of Metabolomics (LABMET), State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.

出版信息

Methods Mol Biol. 2025;2913:247-249. doi: 10.1007/978-1-0716-4458-4_23.

Abstract

All biological samples are potentially infectious, requiring vaccination and protective equipment for laboratory personnel. The risk classification of pathogenic microorganisms, including the yellow fever virus (YFV), is based on potential risks to individuals, communities, and the environment. Countries have their own classification systems, with Brazil previously following global standards until 1995. YFV is classified as a Risk Group 3 pathogen by the WHO, necessitating handling in Biosafety Level 3 (BSL3) laboratories. Personnel must be vaccinated against YFV at least 10 days prior to contact, as there have been cases of occupationally acquired infections among healthcare and laboratory workers.

摘要

所有生物样本都具有潜在传染性,实验室人员需要接种疫苗并配备防护装备。包括黄热病毒(YFV)在内的致病微生物的风险分类是基于对个人、社区和环境的潜在风险。各国都有自己的分类系统,巴西在1995年之前一直遵循全球标准。YFV被世界卫生组织列为风险等级3类病原体,必须在生物安全3级(BSL3)实验室中进行处理。工作人员必须在接触前至少10天接种YFV疫苗,因为医护人员和实验室工作人员中曾出现过职业性感染病例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验